NYC Fund Launch: Colbeck Capital Launches $400M Strategic Income Direct Lending Vertical
New York-based Colbeck Capital Management launched Colbeck Strategic Income with $400M on June 24, 2026, expanding its middle-market private credit platform.
Fund closes signal where limited partner capital is flowing and which investment theses GPs believe will outperform over the next decade. Our fund-close coverage tracks debut funds, flagship successors, sector specialists, and emerging managers raising new vehicles.
See the latest venture capital fund closes and launches below.
New York-based Colbeck Capital Management launched Colbeck Strategic Income with $400M on June 24, 2026, expanding its middle-market private credit platform.
New York-based Gutter Capital announced the $75M close of Fund III on June 15, 2026, alongside applications for the second cohort of its NYC Elbow Grease accelerator.
New York-based Star51 Capital announced the first close of its inaugural medtech venture fund on June 11, 2026, anchored by Abbott and Mayo Clinic.
New York-based Animal Capital announced the $33M close of Fund III on June 11, 2026, continuing its early-stage consumer technology investment strategy.
New York-based Blue Cloud Ventures announced the final close of Fund V on June 2, 2026, bringing total AUM above $1 billion for enterprise SaaS and AI growth investing.
New York-based Opto Investments announced the close of its AI-focused venture fund on May 28, 2026, providing RIA and family office clients exposure to foundational AI infrastructure.
Former Coatue partner Kris Fredrickson closed Verified Capital Fund I at $175M in July 2025 — a concentrated 8–10 bet strategy backed by Harvey AI, Coinbase, and Instacart founders.
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Greenwich and Miami-based Glade Brook Capital closed Strategic Growth Fund IV at $515 million on July 22, 2025, targeting FinTech, AI, SpaceTech, and DefenseTech growth equity.
New York City-based Betaworks announced the $66M close of Fund III on July 22, 2025, continuing its legacy of backing creative technologists building AI-native products.
Houston-based Modi Ventures closed its oversubscribed second fund at $88 million on July 16, 2025, investing at the intersection of AI, biology, and medical technology.
New York-based Quartus Capital Partners closed its Quartus AI Fund LP at $50M+ on July 14, 2025, deploying into growth-stage AI ventures across healthcare, education, and logistics.